Chromadex Corp
NASDAQ:CDXC

Watchlist Manager

Chromadex Corp

NASDAQ:CDXC

Watchlist

Dividends

Price: 6.7575 USD -0.18% Market Closed

Market Cap: 513.1m USD

Have any thoughts about
Chromadex Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 6.7575 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

CDXC Alert

Chromadex Corp

6.7575

-0.0125 (-0.18%)

52 Week Range	1.33 6.99
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Chromadex Corp

What unique competitive advantages
does Chromadex Corp hold over its rivals?

What risks and challenges
does Chromadex Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Chromadex Corp.

What unique competitive advantages
does Chromadex Corp hold over its rivals?

What risks and challenges
does Chromadex Corp face in the near future?

Has there been any significant insider trading activity
in Chromadex Corp recently?

Summarize the latest earnings call
of Chromadex Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Chromadex Corp.

Provide P/S
for Chromadex Corp.

Provide P/E
for Chromadex Corp.

Provide P/OCF
for Chromadex Corp.

Provide P/FCFE
for Chromadex Corp.

Provide P/B
for Chromadex Corp.

Provide EV/S
for Chromadex Corp.

Provide EV/GP
for Chromadex Corp.

Provide EV/EBITDA
for Chromadex Corp.

Provide EV/EBIT
for Chromadex Corp.

Provide EV/OCF
for Chromadex Corp.

Provide EV/FCFF
for Chromadex Corp.

Provide EV/IC
for Chromadex Corp.

Show me price targets
for Chromadex Corp made by professional analysts.

What are the Revenue projections
for Chromadex Corp?

How accurate were the past Revenue estimates
for Chromadex Corp?

What are the Net Income projections
for Chromadex Corp?

How accurate were the past Net Income estimates
for Chromadex Corp?

What are the EPS projections
for Chromadex Corp?

How accurate were the past EPS estimates
for Chromadex Corp?

What are the EBIT projections
for Chromadex Corp?

How accurate were the past EBIT estimates
for Chromadex Corp?

Compare the revenue forecasts
for Chromadex Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Chromadex Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Chromadex Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Chromadex Corp compared to its peers.

Compare the P/E ratios
of Chromadex Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Chromadex Corp with its peers.

Analyze the financial leverage
of Chromadex Corp compared to its main competitors.

Show all profitability ratios
for Chromadex Corp.

Provide ROE
for Chromadex Corp.

Provide ROA
for Chromadex Corp.

Provide ROIC
for Chromadex Corp.

Provide ROCE
for Chromadex Corp.

Provide Gross Margin
for Chromadex Corp.

Provide Operating Margin
for Chromadex Corp.

Provide Net Margin
for Chromadex Corp.

Provide FCF Margin
for Chromadex Corp.

Show all solvency ratios
for Chromadex Corp.

Provide D/E Ratio
for Chromadex Corp.

Provide D/A Ratio
for Chromadex Corp.

Provide Interest Coverage Ratio
for Chromadex Corp.

Provide Altman Z-Score Ratio
for Chromadex Corp.

Provide Quick Ratio
for Chromadex Corp.

Provide Current Ratio
for Chromadex Corp.

Provide Cash Ratio
for Chromadex Corp.

What is the historical Revenue growth
over the last 5 years for Chromadex Corp?

What is the historical Net Income growth
over the last 5 years for Chromadex Corp?

What is the current Free Cash Flow
of Chromadex Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Chromadex Corp.

P/E
Price to Earnings

346

Current

-10.4

Median

33.1

Industry

Higher than median

Higher than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

346

Market Cap

513.8m USD

Net Income

1.5m USD

All Countries

Forward Multiples

			Market Cap	P/E
US		Chromadex Corp NASDAQ:CDXC	513.8m USD	346
US	P	PerkinElmer Inc LSE:0KHE	1.4T USD	5 412.6
US		Thermo Fisher Scientific Inc NYSE:TMO	210.8B USD	34.3
US		Danaher Corp NYSE:DHR	177.9B USD	45.7
KR		Samsung Biologics Co Ltd KRX:207940	71.2T KRW	69.2
CH		Lonza Group AG SIX:LONN	39.5B CHF	68.9
US		IQVIA Holdings Inc NYSE:IQV	39.9B USD	28.4
US		Agilent Technologies Inc NYSE:A	39.3B USD	27.8
US		Mettler-Toledo International Inc NYSE:MTD	28.1B USD	35.7
US		Illumina Inc NASDAQ:ILMN	24B USD	-15.2
US		West Pharmaceutical Services Inc NYSE:WST	23.7B USD	47.4

				Earnings Growth
US		Chromadex Corp NASDAQ:CDXC	Average P/E: 611.6 346	N/A
US	P	PerkinElmer Inc LSE:0KHE	5 412.6	5%
US		Thermo Fisher Scientific Inc NYSE:TMO	34.3	68%
US		Danaher Corp NYSE:DHR	45.7	44%
KR		Samsung Biologics Co Ltd KRX:207940	69.2	76%
CH		Lonza Group AG SIX:LONN	68.9	112%
US		IQVIA Holdings Inc NYSE:IQV	28.4	90%
US		Agilent Technologies Inc NYSE:A	27.8	47%
US		Mettler-Toledo International Inc NYSE:MTD	35.7	33%
US		Illumina Inc NASDAQ:ILMN	Negative Multiple: -15.2	N/A
US		West Pharmaceutical Services Inc NYSE:WST	47.4	9%

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

663.3

2-Years Forward

P/E

76.5

3-Years Forward

P/E

40.2

Chromadex Corp
NASDAQ:CDXC

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Chromadex Corp NASDAQ:CDXC

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Chromadex Corp
NASDAQ:CDXC

P/E
Price to Earnings